Your browser doesn't support javascript.
loading
EPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancer.
Husa, Anna-Maria; Magic, Zeljana; Larsson, Malin; Fornander, Tommy; Pérez-Tenorio, Gizeh.
Affiliation
  • Husa AM; Department of Clinical and Experimental Medicine, Division of Oncology, Linköping University, Linköping, Sweden.
  • Magic Z; Current address: CCRI, Children's Cancer Research Institute, St. Anna Kinderkrebsforschung e.V., Vienna, Austria.
  • Larsson M; Department of Clinical and Experimental Medicine, Division of Oncology, Linköping University, Linköping, Sweden.
  • Fornander T; Bioinformatics Infrastructure for Life Sciences (BILS) and Department of Physics, Chemistry and Biology, Linköping University, Linköping, Sweden.
  • Pérez-Tenorio G; Department of Oncology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden.
Oncotarget ; 7(16): 21362-80, 2016 Apr 19.
Article in En | MEDLINE | ID: mdl-26870995
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Receptors, Eph Family / Receptor, EphB2 / Ephrins Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Oncotarget Year: 2016 Type: Article Affiliation country: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Receptors, Eph Family / Receptor, EphB2 / Ephrins Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Oncotarget Year: 2016 Type: Article Affiliation country: Sweden